Breast Cancer - Research Protocols

Alliance A011202:

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patietns (CT1-3 N1) Whow Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
LifeBridge Sites: Sinai Hospital of Baltimore, Northwest Hospital, William E Kahlert Regional Cancer Center 

Breast Cancer Collaborative Registry(Non-treatment Registry)

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)
LifeBridge Sites: Sinai Hospital of Baltimore, Northwest Hospital, William E Kahlert Regional Cancer Center

EAZ171:

Prospective validation trial of taxanes therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women
LifeBridge Sites: Sinai Hospital of Baltimore, Northwest Hospital, William E Kahlert Regional Cancer Center 

EPIK-B3:

A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) nutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation
LifeBridge Sites: Sinai Hospital of Baltimore, Northwest Hospital, William E Kahlert Regional Cancer Center 

Alliance A191901:

Optimizing Endocrine Therapy Through Motivational Interviewing and Test Interventions
LifeBridge Sites: Sinai Hospital of Baltimore, Northwest Hospital, William E Kahlert Regional Cancer Center 


For more information about ongoing clinical trials at the Alvin & Lois Lapidus Cancer Institute, please contact the oncology research team at 410-601-6120